The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients
Clinical Transplantation · 2026
DOI: 10.1111/ctr.70480 ↗At a glance
Journal article in Clinical Transplantation, 2026. Written by Qingyong Xu and 4 co-authors. Institution: Division of Transplant Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. Major MEDLINE topics: Graft Rejection, Liver Transplantation, Isoantibodies, HLA Antigens. 35 references. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Background
Antibodies to donor HLA (DSA) and non‐HLA antigens are associated with detrimental outcomes in kidney, heart, and lung transplants. Such data are scarce in liver transplants (LTx). We aim to study the roles of DSA and non‐HLA antibodies in T‐cell‐mediated rejection (TCMR) of LTx.
Methods
Allograft biopsies ( n = 103) from adult LTx recipients were studied. Biopsy‐paired serums were retrospectively tested for anti‐angiotensin II type 1 receptor (AT1R) and the Luminex panel of 60 non‐HLA Antibodies.
Results
TCMR was detected in 59 of 103 (57.3%) biopsies. Twenty‐six biopsies were categorized as moderate‐severe (MS‐TCMR), 77 as negative‐mild (NM‐TCMR). DSA was positive in 95/103 (92.2%) cases and wasn't associated with MS‐TCMR. Anti‐AT1R antibodies were elevated in serum paired with MS‐TCMR vs. NM‐TCMR (18.8[15.2–40.0] vs. 13.0[10.0–21.5] U/ml, p < 0.01). Positive anti‐AT1R antibodies were associated with a higher incidence of MS‐TCMR (HR = 12.4[1.5–101.6], p = 0.02). A panel of 18 non‐HLA Abs was significantly associated with MS‐TCMR. The number of panel‐18 non‐HLA antibodies was higher with MS‐TCMR vs. NM‐TCMR (3[2–5] vs. 1[0–1], p < 0.001). The incidence of MS‐TCMR was higher in cases with panel‐18 non‐HLA antibodies ≥3 vs.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Transplant Pathology, Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
ORCID profiles: Qingyong Xu, Nigar A Khurram, Carol Bentlejewski, Anthony J Demetris, Adriana Zeevi
Cite
APA
Xu, Q., Khurram, N. A., Bentlejewski, C., Demetris, A. J., & Zeevi, A. (2026). The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients. Clinical Transplantation. https://doi.org/10.1111/ctr.70480
Vancouver
Xu Q, Khurram NA, Bentlejewski C, Demetris AJ, Zeevi A. The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients. Clinical Transplantation. 2026. doi:10.1111/ctr.70480
BibTeX
@article{Xu2026,
author = {Xu, Qingyong and Khurram, Nigar A and Bentlejewski, Carol and Demetris, Anthony J and Zeevi, Adriana},
title = {The Presence of Non‐HLA Antibody With DSA Is Associated With Moderate to Severe T Cell‐Mediated Rejection in Liver Transplant Recipients},
journal = {Clinical Transplantation},
year = {2026},
doi = {10.1111/ctr.70480}
}
EUVIMED